Nimodipine
尼莫地平
Report date: 2026/03/19 20:00:18
NME
Base Information
Drug NameNimodipine
Drug Alias Name +[17]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1985/01/01
Country/Territory +[13]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A
Develop Information
Active CompaniesYale UniversityJohns Hopkins UniversityBayer AG +[6]
Inactive CompaniesNational Institute On Drug AbuseEdge Therapeutics IncBayer Pharms Corp +[4]
Active Indications +[6]
Inactive Indications